Table 1 Study cohort characteristics of preterm infants.
(n = 50) | |
|---|---|
DHA supplementation (yes, %) | 26 (52.0) |
Gestational age at birth (weeks, median ± SD) | 26.4 (±1.7) |
(Postnatal) age at collection (days; median ± SD) | |
T1 | 4.2 (±1.6) |
T2 | 65.7 (±14.6) |
Sex (male, %) | 27 (54.0) |
Singleton birth (n, %) | 35 (70) |
Birth type (n, %) | |
Vaginal | 17 (34.0) |
C.S. in labor | 12 (24.0) |
C.S. no labor | 21 (42.0) |
Enteral feeds on discharge (n, %) | |
Breastmilk | 25 (50.0) |
Formula | 18 (36.0) |
Breastmilk and formula | 6 (12.0) |
Unknown | 1 (2.0) |
BPDa (n,%) | 20 (42.0) |
Sepsis (n, %) | 13 (26.0) |
Collected samples for both time points (n, %) | 41 (82.0) |
Infants with tracheal aspirate collected (n, %) | 14 (28.0) |
(n = 40)b | |
|---|---|
Probiotics (n, %) | 39 (97.5) |
Antibiotics (n, %) | 39 (97.5) |
Number of antibiotic doses (median ± SD) | 26 (±44.6) |
Antifungals (n, %) | 39 (97.5) |
Number of antifungal doses (median ± SD) | 55 (±57.7) |
